查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553691

化疗引起的脱髮症(CIA) 治疗设备市场规模、份额和趋势分析报告：2024-2030 年按产品、销售形式、适应症、最终用途、地区和细分市场进行的预测

Chemotherapy-induced Alopecia Treatment Device Market Size, Share & Trends Analysis Report By Product (Manual Cooling Systems, Automated Cooling Systems), By Sales Modality, By Indication, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 145 Pages | 商品交期: 2-10个工作天内

价格

化疗引起的脱髮症（CIA）治疗设备市场成长与趋势：

根据统计，到2030年，全球化疗引起的脱髮(CIA)治疗设备市场规模预计将达到1.747亿美元，到2030年，全球化疗引起的脱髮症(CIA)治疗设备市场规模预计将达到1.747亿美元。 View Research, Inc. 的最新报告预计复合年增长率为14.6%。

推动市场的主要因素是化疗采用率的增加、技术进步、意识和采用率的提高以及政府措施。美国癌症协会预测，到 2024 年，美国将新增约 67,880 例宫癌病例，约 13,250 名女性将死于此病。如此高的病例量凸显了对有效治疗方案的持续需求，包括化疗引起的脱髮症(CIA) 治疗设备。由于许多患者接受化疗，对解决脱髮问题的解决方案的需求不断增加，这凸显了 CIA 治疗设备在支持女性癌症治疗过程中的重要性。

化疗引起的脱髮症（CIA）治疗设备的进步正在推动市场成长。根据 2024 年 3 月发表的 NCBI 论文，冷帽是一种减少化疗引起的脱髮症(CIA)的非药理学的处置方法，因其在治疗期间保留头髮的潜力而得到认可。在一项研究中，检验了手动冷盖系统在不同患者群体中的实际有效性和耐受性，在 100 名开始冷盖的患者中，95% 完成了该过程。中位数头髮保留率为 75%，据报道，92.1% 的患者保留了 50% 或更多的头髮。

化疗引起的脱髮症(CIA) 治疗设备市场报告亮点：

  • 由于产品不断进步、主要企业不断扩大倡议以及癌症发病率不断上升，手动冷却系统细分市场在 2023 年以 52.7% 的最高收益占有率引领市场。
  • 从销售业态来看，租赁销售业以 2023 年销售份额最大的 80.9% 领先市场。患者对头皮冷却系统的认识不断提高，推动了租赁选择的需求。随着越来越多的人寻求减轻化疗引起的脱髮，医疗保健提供者正在扩大其服务范围，包括租赁计划以增加可及性。
  • 有迹象表明，乳癌领域在2023年以66.9%的最大销售份额引领市场。乳癌发病率的上升、技术的进步和意识的提高正在推动市场的成长。
  • 按最终用途划分，医院细分市场在 2023 年以 44.8% 的最高收益占有率引领市场。医院正在将这些 CIA 设备纳入其肿瘤科，为患者提供一种行之有效的方法来缓解化疗相关的脱髮。
  • 北美地区在 2023 年以 52.8% 的最大收益占有率主导市场。癌症患者数量的增加、产品的推出、监管部门的核准和先进的医疗基础设施正在推动北美对 CIA 治疗设备的需求。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章全球化疗诱发脱髮症(CIA) 治疗设备市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 化疗引起的脱髮症（CIA）治疗设备市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章化疗引起的脱髮症（CIA）治疗设备市场：按产品估计和趋势分析

  • 化疗诱发脱髮症(CIA) 治疗设备市场：产品仪表板
  • 化疗脱髮症（CIA）治疗器材市场：产品波动分析
  • 2018-2030年化疗引起的脱髮症（CIA）治疗设备市场规模及预测与趋势分析（按产品）
  • 手动冷却系统
  • 自动冷却系统

第五章化疗引起的脱髮症（CIA）治疗设备市场：按销售形式估算和趋势分析

  • 化疗诱发脱髮症(CIA) 治疗设备市场：销售方式仪表板
  • 化疗脱髮症（CIA）治疗器材市场：销售业态波动分析
  • 2018-2030年化疗引起的脱髮症（CIA）治疗设备市场规模、预测和趋势分析（按销售形式）
  • 出租销售
  • 直销

第六章化疗引起的脱髮症（CIA）治疗设备市场：按适应症的估计和趋势分析

  • 化疗诱发脱髮症(CIA) 治疗设备市场：适应症仪表板
  • 化疗引起的脱髮症（CIA）治疗设备市场：适应症变化分析
  • 2018-2030年化疗引起的脱髮症（CIA）治疗设备市场规模及预测与趋势分析（依适应症）
  • 乳癌
  • 摄护腺癌
  • 卵巢癌
  • 子宫癌
  • 其他的

第七章化疗引起的脱髮症（CIA）治疗设备市场：按最终用途分类的估计和趋势分析

  • 化疗诱发脱髮症(CIA) 治疗设备市场：最终用途仪表板
  • 化疗引起的脱髮症（CIA）治疗设备市场：最终用途变化分析
  • 2018-2030 年化疗引起的脱髮症(CIA) 治疗设备市场规模、预测和趋势分析（按最终用途）
  • 医院
  • 癌症中心
  • 门诊

第 8 章化疗引起的脱髮症(CIA) 治疗设备市场：按国家、产品、适应症、销售形式和最终用途分類的区域估计和趋势分析

  • 全球化疗诱发脱髮症(CIA) 治疗设备市场：区域仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第9章 竞争格局

  • 主要製造商的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • Dignitana
    • Paxman
    • Penguin Cold Caps
    • Chemotherapy Cold Caps, Inc.
    • Aspen Systems, LLC's
    • Cooler Heads Care, Inc.
    • Arctic Cold Caps, LLC
    • Stemtech Medical Devices
    • Polar Cold Caps LLC
Product Code: GVR-4-68040-433-6

Chemotherapy-induced Alopecia Treatment Device Market Growth & Trends:

The global chemotherapy induced alopecia treatment device market size is anticipated to reach USD 174.7 million by 2030 and is projected to grow at a CAGR of 14.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The primary factors driving the market are increasing chemotherapy adoption, technological advancements, growing awareness & adoption, and government initiatives. In 2024, the American Cancer Society forecasts around 67,880 new cases of uterine cancer in the United States, with approximately 13,250 women expected to die from the disease. This significant number of cases highlights an ongoing need for effective treatment options, including chemotherapy-induced alopecia (CIA) treatment devices. As many of these patients undergo chemotherapy, there will be an increased demand for solutions that address hair loss, underscoring the importance of CIA treatment devices in supporting women through their cancer treatment journey

Advancements in chemotherapy-induced alopecia (CIA) treatment devices are driving the market growth. According to NCBI article published in March 2024, Cold capping, a non-pharmacologic approach to reducing chemotherapy-induced alopecia (CIA), is gaining recognition for its potential to preserve hair during treatment. A study reviewing the real-world effectiveness and tolerability of a manual cold capping system across diverse patient demographics found that 95% of the 100 patients who initiated cold capping completed the process. The median hair retention was reported at 75%, with 92.1% of patients achieving favorable results, defined as retaining 50% or more of their hair.

Chemotherapy-induced Alopecia Treatment Device Market Report Highlights:

  • The manual cooling systems segment led the market with the largest revenue share of 52.7% in 2023, due to ongoing product advancements, growing initiatives by key companies, and increasing cancer prevalence
  • Based on sales modality, the rental sales segment led the market with the largest revenue share of 80.9% in 2023. Growing patient awareness of scalp cooling systems has increased demand for rental options. As more individuals seek to mitigate chemotherapy-induced hair loss, healthcare providers are expanding their services to include rental programs, enhancing accessibility
  • Based on indication, the breast cancer segment led the market with the largest revenue share of 66.9% in 2023. Rising incidence of breast cancer, technological advancement, and growing awareness drive the market growth
  • Based on end use, the hospital segment led the market with the largest revenue share at 44.8% in 2023. Hospitals are integrating these CIA devices into their oncology departments to offer patients a proven method for mitigating chemotherapy-related hair loss
  • North America dominated the market with the largest revenue share of 52.8% in 2023. Rising cancer cases, product launches, regulatory approvals, and advanced healthcare infrastructure drive North America's demand for CIA treatment devices

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Sales Modality
    • 1.2.3. Indication
    • 1.2.4. End Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Segment
    • 2.2.2. Sales Modality Segment
    • 2.2.3. Indication Segment
    • 2.2.4. End Use Segment
    • 2.2.5. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Chemotherapy Induced Alopecia (CIA) Treatment Device Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising incidence of cancer
      • 3.2.1.2. Increasing prevalence of chemotherapy-induced alopecia
      • 3.2.1.3. Technological advancements
      • 3.2.1.4. Growing Awareness and Adoption
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Low product awareness
      • 3.2.2.2. Limited number of manufacturers
  • 3.3. Chemotherapy Induced Alopecia (CIA) Treatment Device Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Product Estimates & Trend Analysis

  • 4.1. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Product Dashboard
  • 4.2. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Product Movement Analysis
  • 4.3. Chemotherapy Induced Alopecia (CIA) Treatment Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Manual Cooling Systems
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Automated Cooling Systems
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Sales Modality Estimates & Trend Analysis

  • 5.1. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Sales Modality Dashboard
  • 5.2. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Sales Modality Movement Analysis
  • 5.3. Chemotherapy Induced Alopecia (CIA) Treatment Device Market Size & Forecasts and Trend Analysis, by Sales Modality, 2018 to 2030 (USD Million)
  • 5.4. Rental Sales
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Direct Sales
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Indication Estimates & Trend Analysis

  • 6.1. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Indication Dashboard
  • 6.2. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Indication Movement Analysis
  • 6.3. Chemotherapy Induced Alopecia (CIA) Treatment Device Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 6.4. Breast Cancer
    • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5. Prostate Cancer
    • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.6. Ovarian Cancer
    • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.7. Uterine Cancer
    • 6.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: End Use Estimates & Trend Analysis

  • 7.1. Chemotherapy Induced Alopecia (CIA) Treatment Device market: End Use Dashboard
  • 7.2. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: End Use Movement Analysis
  • 7.3. Chemotherapy Induced Alopecia (CIA) Treatment Device Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5. Cancer Centers
    • 7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 7.6. Outpatient Clinics
    • 7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Regional Estimates & Trend Analysis by Country, Product, Indication, Sales Modality, & End Use

  • 8.1. Global Chemotherapy induced alopecia (CIA) treatment device market: Regional Dashboard
  • 8.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 8.3. North America
    • 8.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamics
      • 8.3.4.2. Regulatory framework/ reimbursement structure
      • 8.3.4.3. Competitive scenario
      • 8.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.8. Norway
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.9. Denmark
      • 8.4.9.1. Key country dynamics
      • 8.4.9.2. Regulatory framework/ reimbursement structure
      • 8.4.9.3. Competitive scenario
      • 8.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.3. Japan
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.7. South Korea
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework/ reimbursement structure
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.3. South Africa
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2023
    • 9.3.4. Dignitana
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Paxman
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Penguin Cold Caps
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Chemotherapy Cold Caps, Inc.
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Aspen Systems, LLC's
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Cooler Heads Care, Inc.
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Arctic Cold Caps, LLC
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Stemtech Medical Devices
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Polar Cold Caps LLC
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 Global Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 5 Global Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 6 Global Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030
  • Table 7 Global Chemotherapy induced alopecia (CIA) treatment device market, by region, 2018 - 2030 (USD Million)
  • Table 8 North America Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 10 North America Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 11 North America Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 12 North America Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 15 U.S. Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 16 U.S. Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Canada Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 18 Canada Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 19 Canada Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 20 Canada Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 21 Mexico Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 22 Mexico Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 23 Mexico Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 24 Mexico Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Europe Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 26 Europe Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 27 Europe Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 28 Europe Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 29 Europe Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 30 UK Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 31 UK Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 32 UK Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 33 UK Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 34 Germany Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 35 Germany Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 36 Germany Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 37 Germany Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 38 France Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 39 France Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 40 France Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 41 France Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Italy Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 43 Italy Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 44 Italy Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 45 Italy Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 46 Spain Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 47 Spain Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 48 Spain Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 49 Spain Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 50 Denmark Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 51 Denmark Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 52 Denmark Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 53 Denmark Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 54 Sweden Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 55 Sweden Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 56 Sweden Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 57 Sweden Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 58 Norway Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 59 Norway Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 60 Norway Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 61 Norway Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Japan Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 68 Japan Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 69 Japan Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 70 Japan Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 71 China Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 72 China Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 73 China Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 74 China Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 75 India Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 76 India Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 77 India Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 78 India Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 79 Australia Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 80 Australia Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 81 Australia Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 82 Australia Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 83 Australia Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 84 Thailand Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 85 Thailand Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 86 Thailand Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 87 Thailand Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 88 South Korea Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 89 South Korea Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 90 South Korea Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 91 South Korea Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 92 Latin America Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 93 Latin America Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 94 Latin America Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 95 Latin America Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 96 Latin America Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 97 Brazil Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 98 Brazil Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 99 Brazil Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 100 Brazil Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 101 Argentina Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 102 Argentina Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 103 Argentina Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 104 Argentina Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 105 MEA Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 106 MEA Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 107 MEA Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 108 MEA Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 109 MEA Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 110 South Africa Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 111 South Africa Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 112 South Africa Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 113 South Africa Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 117 Saudi Arabia Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 118 UAE Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 119 UAE Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 120 UAE Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 121 UAE Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 125 Kuwait Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 126 Participant's overview
  • Table 127 Financial performance
  • Table 128 Key companies undergoing expansions
  • Table 129 Key companies undergoing acquisitions
  • Table 130 Key companies undergoing collaborations
  • Table 131 Key companies launching new products
  • Table 132 Key companies undergoing partnerships
  • Table 133 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Chemotherapy induced alopecia (CIA) treatment device market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Chemotherapy induced alopecia (CIA) treatment device market revenues, 2023 (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Chemotherapy induced alopecia (CIA) treatment device market Product outlook:
  • Fig. 14 Chemotherapy induced alopecia (CIA) treatment device market: Product movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global manual cooling systems market, 2018 - 2030 (USD Million)
  • Fig. 17 Global automated cooling systems market, 2018 - 2030 (USD Million)
  • Fig. 18 Chemotherapy induced alopecia (CIA) treatment device market Sales modality outlook:
  • Fig. 19 Chemotherapy induced alopecia (CIA) treatment device market: Sales modality movement analysis
  • Fig. 20 Global rental sales market, 2018 - 2030 (USD Million)
  • Fig. 21 Global direct sales market, 2018 - 2030 (USD Million)
  • Fig. 22 Chemotherapy induced alopecia (CIA) treatment device market Indication outlook:
  • Fig. 23 Chemotherapy induced alopecia (CIA) treatment device market: Indication movement analysis
  • Fig. 24 Global breast cancer market, 2018 - 2030 (USD Million)
  • Fig. 25 Global prostate cancer market, 2018 - 2030 (USD Million)
  • Fig. 26 Global ovarian cancer market, 2018 - 2030 (USD Million)
  • Fig. 27 Global uterine cancer market, 2018 - 2030 (USD Million)
  • Fig. 28 Global others market, 2018 - 2030 (USD Million)
  • Fig. 29 Chemotherapy induced alopecia (CIA) treatment device market End Use outlook:
  • Fig. 30 Chemotherapy induced alopecia (CIA) treatment device market: End Use movement analysis
  • Fig. 31 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 32 Global cancer centers market, 2018 - 2030 (USD Million)
  • Fig. 33 Global outpatient clinics market, 2018 - 2030 (USD Million)
  • Fig. 34 Regional market place: Key takeaways
  • Fig. 35 North America Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 40 Germany Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 41 UK Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 42 France Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 47 China Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 48 India Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 49 Australia Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 52 MEA Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 55 Market Participant Categorization
  • Fig. 56 Strategy mapping